ASM Online Program

ASM ONLINE PROGRAM
30th November – 2nd December

Registration to the online ASM includes access to the full program below, the Meeting Hub, Exhibition Hall, Poster Lounge and all virtual networking sessions. Attendees do not need to identify which sessions they wish to attend before the event.The ASM aims to provide most sessions on-demand to registered delegates for a four week period after the event.  Availability of recorded sessions for on-demand will be dependent on consent received from presenters.  Where consent has not been received and the session will only be available live on the day of presentation this will be indicated in the program below by 30th October 2020.

Click here to register.
Program times are listed in AEDT. To convert program times to your timezone, CLICK HERE
Monday, 30th November 2020
SPEED NETWORKING ICEBREAKER
0930-1000
Take this opportunity to meet colleagues, sponsors and speakers through small group meetings. Delegates will be randomly allocated through a progression of four-person video group chats.  You never know who you might meet!
WELCOME & ORIENTATION
1000-1020
PLENARY #1
POLYCYSTIC KIDNEY DISEASE: FROM BEDSIDE TO BENCH TO CLINICAL HORIZON
1020-1120
Dr Lisa Guay-Woodford
McGehee Joyce Professor of Pediatrics at the Children’s National Medical Center (CNMC), Washington DC
1120-1130 REFRESHMENT BREAK
Stretch, stand up, get ready for the breakout sessions…which will you attend?
CONCURRENT SESSIONS
1130-1300
The following sessions run concurrently and attendees can attend any without prior booking. Delegates may also switch between sessions after they have commenced. Unless otherwise indicated all sessions will be recorded for On-Demand viewing after the ASM.

MODELLING KIDNEY DISEASES SYMPOSIUM

View Session Details

This 90 minute session will consist of 4 x presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Melissa Little, Murdoch Children’s Research Institute

Aude Dorison, Murdoch Children’s Research Institute

Tom Forbes, Royal Children’s Hospital

Ian Smyth, Monash University

#1: REBUILDING A KIDNEY: HOW FAR ARE WE FROM TREATMENT #2: CONGENITAL NEPHROTIC SYNDROME: WHAT CAN WE LEARN FROM KIDNEY ORGANOIDS? #3: MODELLING GENETIC TUBULAR KIDNEY DISEASE WITH KIDNEY ORGANOIDS REGENERATED FROM PATIENT INDUCED PLURIPOTENT STEM CELLS #4: A MUTATION AFFECTING LAMININ ALPHA 5 POLYMERISATION GIVES RISE TO A SYNDROMIC DEVELOPMENTAL DISORDER 

Close Session Details

CHRONIC KIDNEY DISEASE (CKD) SYMPOSIUM

View Session Details

This 90 minute session will consist of 3 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Matthew Roberts, Deputy Director of Nephrology, Eastern Health

Brendon Neuen, NHMRC Postgraduate Scholar at The George Institute, Australia

Eric Tan, Research Fellow/NHMRC Early Career Research Fellow, Swinburne University of Technology, Australia

#1: CARDIOVASCULAR BIOMARKERS AND MECHANISMS OF DISEASE – WHERE ARE WE NOW? #2: SGLT2 INHIBITION IN CKD: CLINICAL IMPACT #3: CHARACTERISING NEUROCOGNITIVE IMPAIRMENTS ACROSS THE STAGES OF CHRONIC KIDNEY DISEASE

Close Session Details

PAEDIATRIC SYMPOSIUM – TRANSITION TO ADULT CARE

View Session Details

This 90 minute session will consist of 4 x 15-minute presentations followed by a 30-minute live Q&A where speakers will answer questions submitted by the audience.

Moderator: Anna Francis

Chanel Prestidge, Starship Children’s Hospital

Rob Carroll, American Society Of Immunogenetics and Histocompatibility 

Shilpa Jesudason, Royal Adelaide Hospital’s Central Northern Adelaide Renal and Transplant Service

Luke Macauley, University of Adelaide

#1: PAEDIATRIC PERSPECTIVE #2: ADULT PERSPECTIVE #3: KHA (KIDNEY HEALTH AUSTRALIA) AND THE CONSUMER PERSPECTIVES #4: KHA (KIDNEY HEALTH AUSTRALIA) AND THE CONSUMER PERSPECTIVES

Close Session Details

PRECISION DOSING: OPTIMIZING CRITICAL DOSE DRUPS IN DIALYSIS & TRANSPLANTATION SYMPOSIUM

View Session Details

This 90 minute session will consist of 3 x 22-minute presentations followed by a 20-minute live Q&A where speakers will answer questions submitted by the audience.

Moderator: David Metz

Katherine Barraclough, Nephrologist, Royal Melbourne Hospital.

David Metz, Paediatric Nephrologist & Clinical Pharmacologist, Royal Children’s Hospital Melbourne.

Darren Roberts, Nephrologist & Clinical Pharmacologist, St Vincent’s Hospital Sydney.

#1: DOSING OF MYCOPHENOLATE AND TACROLIMUS IN KIDNEY TRANSPLANTATION: WHAT IS THE EVIDENCE? #2: APPLIED PHARMACOKINETIC TOOLS AND TRICKS TO OPTIMIZE MYCOPHENOLIC ACID (AND TACROLIMUS) IN KIDNEY TRANSPLANTATION #3: DOSE-ADJUSTMENT DURING HAEMODIALYSIS OR APHERESIS TO OPTIMISE PATIENT OUTCOMES

Close Session Details

1300-1400 EXHIBITION & REFRESHMENT BREAK
Visit with our sponsors in the Exhibition Hall
PLENARY #2
1400-1605
Young Investigator Award Session
12 minute live presentations followed by questions from the audience.  
BASIC SCIENCE
LATENT CYTOMEGALOVIRUS INFECTION ENHANCES ANTI-MYELOPEROXIDASE AUTOIMMUNITY AND GLOMERULONEPHRITIS IN MICE
Juli Jaw
THE EFFECTS OF GESTATIONAL HYDRALAZINE ON OBESITY-RELATED CHRONIC KIDNEY DISEASE IN OFFSPRING
Benjamin P. Larkin
NECROPTOSIS IN RENAL ISCHAEMIA REPERFUSION INJURY
Aspasia Pefanis
HEAT TREATED DIET INTAKE DRIVES INTESTINAL PERMEABILITY, COMPLEMENT ACTIVATION AND ALBUMINURIA IN RODENTS
Matthew Snelson
CLINICAL SCIENCE
DIETARY POTASSIUM INTAKE AND ALL-CAUSE MORTALITY IN ADULTS UNDERGOING HEMODIALYSIS: THE DIET-HD COHORT STUDY
Amélie Bernier-Jean
COMPARISON BETWEEN FREEHAND AND NEEDLE GUIDE TECHNIQUES FOR TEACHING PERCUTANEOUS RENAL BIOPSY: A RANDOMISED CONTROLLED TRIAL
Elizabeth Downie
EVALUATING THE FEASIBILITY OF A MOBILE PHONE TEXT MESSAGING INTERVENTION ON IMPROVING DIETARY BEHAVIOURS IN PATIENTS RECEIVING HAEMODIALYSIS (KIDNEYTEXT)
Jessica Dawson
THE FILTRATION IN THE NEUROPATHY OF END-STAGE KIDNEY DISEASE (FINESSE) RANDOMISED CONTROLLED TRIAL
Amy Kang
1605 -1615 REFRESHMENT BREAK
Stretch, stand up, make a contact in the Meeting Hub, browse the Exhibition or the Posters.  Get ready for the breakout sessions…which will you attend?
CONCURRENT SESSIONS
1615-1745
The following sessions run concurrently and attendees can attend any without prior booking. Delegates may also switch between sessions after they have commenced. Unless otherwise indicated all sessions will be recorded for On-Demand viewing after the ASM.

KIDNEY HEALTH AUSTRALIA (KHA) CLINICAL SCIENCE AWARD SESSION

BASIC SCIENCE SYMPOSIUM

View Session Details

This 90 minute session will consist of 3 x 22-minute presentations followed by a 20-minute live Q&A where speakers will answer questions submitted by the audience.

Raelene Pickering, Post-Doctoral Researcher, Department of Diabetes, Monash University

Rob Walker, Department of Medicine, Otago Medical School University; Head of Nephrology, Southern District Health Board; Director of ‘the Kidney in Health and Disease research theme”, University of Otago

Kate Denton, Monash University

#1: TRANSACTIVATION OF RAGE MEDIATED ANGIOTENISIN-INDUCED INFLAMANTION AND ATHEROGENESIS #2: LITHIUM, GSK3 AND RENAL CELL FUNCTION #3: THE ROLE OF THE KIDNEY IN THE CONTROL OF ARTERIAL PRESSURE

Close Session Details

MINI ORALS #1 | GENERAL NEPHROLOGY

View Session Details

This 90 minute session will comprise of pre-recorded 5 minute mini oral presentations followed by a group live Q&A sessions where presenters will answer questions from the audience.

SHOULD WE TREAT AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE WITH AMLODIPINE?
Sean Barton
CHANGES IN PLASMA METABOLITES IN INDIVIDUALS WITH DIABETES ASSOCIATED CHRONIC KIDNEY DISEASE: A CLOSER LOOK AT LIPID PROFILES AND CARDIOVASCULAR RISK
Ashani Lecamwasam
GUT MICROBIOME COMPOSITION REMAINS STABLE IN INDIVIDUALS WITH DIABETES-RELATED EARLY TO LATE STAGE CHRONIC KIDNEY DISEASE
Ashani Lecamwasam
DNA METHYLATION PROFILING IDENTIFIES EPIGENETIC DIFFERENCES BETWEEN EARLY VERSUS LATE STAGES OF DIABETIC CHRONIC KIDNEY DISEASE
Ashani Lecamwasam
ESTABLISHING RECOMMENDED STANDARDS FOR INFORMED CONSENT FOR MAINTENANCE DIALYSIS
Peter Mount
RENAL SUPPORTIVE CARE AT PRINCE OF WALES HOSPITAL: 5-YEAR EXPERIENCE
Lin Lin Myat
BIOMARKERS THAT PREDICT PROGRESSION OF CHRONIC KIDNEY DISEASE MORE ACCURATELY THAN ESTABLISHED CLINICAL PARAMETERS
Evan Owens
KIDNEY FUNCTION AFTER INITIATION AND DISCONTINUATION OF EMPAGLIFLOZIN IN HEART FAILURE PATIENTS WITH AND WITHOUT TYPE 2 DIABETES: INSIGHTS FROM THE EMPERIAL TRIALS
Andrew Sindone
STORIES AND JOURNEYS: UNDERSTANDING THE EXPERIENCE OF LIVING WITH KIDNEY DISEASE AND RECEIVING HAEMODIALYSIS THROUGH STORYTELLING
Leigh Tesch
EFFECT OF LANTHANUM CARBONATE ON ENDOGENOUS CALCIPROTEIN PARTICLES IN CKD PATIENTS – RESULTS FROM A PLACEBO-CONTROLLED RANDOMISED TRIAL
Mark Tiong
MIDKINE EXPRESSION IN KIDNEY BIOPSIES OF PATIENTS WITH ACUTE AND CHRONIC KIDNEY DISEASE
Jeffrey Wang

Close Session Details

MINI ORALS #2 | EXPERIMENTAL TUBOLOINTERSTITIAL DISEASE / HEAMODIALYSIS

MINI ORALS #3 | EPIDEMIOLOGY & PUBLIC HEALTH

View Session Details

This 90 minute session will comprise of pre-recorded 5 minute mini oral presentations followed by a group live Q&A sessions where presenters will answer questions from the audience.

EFFECT OF SEVERE CYCLONE ON INCIDENCE AND CLINICAL PHENOTYPE OF ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) ASSOCIATED RENAL VASCULITIS (AAV) IN CENTRAL QUEENSLAND OF AUSTRALIA
Justin Chan
RISING INCIDENT RATES AND POORER ACCESS TO KIDNEY TRANSPLANTATION AMONG ABORIGINAL CHILDREN AND YOUNG ADULTS IN AUSTRALIA
Swasti Chaturvedi
TEMPORAL CHANGES AND RISK FACTORS ASSOCIATED WITH EARLY MORTALITY ATTRIBUTED TO DIALYSIS WITHDRAWAL IN PATIENTS WITH KIDNEY FAILURE
Jenny Chen
TRENDS IN JOINT REPLACEMENT FOR AUSTRALIAN DIALYSIS AND TRANSPLANT PATIENTS: A DATA LINKAGE STUDY
Christopher Davies
DIALYSIS AND DRIVING: AN ANONYMOUS SURVEY OF PATIENTS RECEIVING DIALYSIS FOR END STAGE KIDNEY DISEASE
Alison Graver
A SMARTPHONE-APP INTERVENTION TO BUILD HEALTH LITERACY SKILLS IN PEOPLE LIVING WITH KIDNEY FAILURE REQUIRING HAEMODIALYSIS – A FEASIBILTY STUDY
Jennifer Isautier
VARIABILITY IN eGFR AND THE RISK OF MAJOR CLINICAL OUTCOMES IN DIABETES: RESULTS FROM ADVANCE
Min Jun
BODY MASS INDEX TRAJECTORIES FROM CHILDHOOD TO MIDLIFE ARE ASSOCIATED WITH SUBCLINICAL KIDNEY DAMAGE IN MIDLIFE
Conghui Liu
CHILDHOOD CARDIORESPIRATORY FITNESS AND EARLY MARKERS OF KIDNEY DISEASE IN MIDDLE AGE: A POPULATION-BASED COHORT STUDY
Conghui Liu
COMBINED CHANGES IN GLOMERULAR FILTRATION RATE AND ALBUMINURIA AND RISK OF KIDNEY DISEASE PROGRESSION IN ROUTINE CLINICAL PRACTICE
Brendon Neuen
AN OVERVIEW OF PATIENT CHARACTERISTICS AND OUTCOMES IN THE CKD.QLD REGISTRY, AUSTRALIA, 2011 to 2018
Zaimin Wang
STATEWIDE LONGITUDINAL ANALYSIS TO PREDICT FUTURE DIALYSIS DEMAND IN WA: PROOF OF CONCEPT STUDY
Helmat Kulkarni

Close Session Details

DAY ONE CONCLUDES
The Networking Hub remains open for scheduled meetings with sponsors and other attendees.  Schedule a meeting through the Networking Hub.
Tuesday, 1st December 2020
SPEED NETWORKING ICEBREAKER
0930-0955
Take this opportunity to meet colleagues, sponsors and speakers through small group meetings. Delegates will be randomly allocated through a progression of four-person video group chats.  You never know who you might meet!
WELCOME
0955-1000
PLENARY #3
CVD INTERVENTIONS IN CKD AND DIALYSIS – WHAT (MIGHT) WORK
1000-1100
Professor Patrick (Paddy) Mark
Professor of Nephrology and Honorary Consultant Nephrologist at the Glasgow Renal and Transplant Unit based at the Queen Elizabeth University Hospital Glasgow
1100-1105
5 min changeover break
CONCURRENT SESSIONS
1105-1235

The following sessions run concurrently and attendees can attend any without prior booking. Delegates may also switch between sessions after they have commenced. Unless otherwise indicated all sessions will be recorded for On-Demand viewing after the ASM.

GENOMIC DATA & IMPLEMENTATION SYMPOSIUM

View Session Details

This 90 minute session will consist of 4 x presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Daniel MacArthur, Broad Institute of MIT

Cathy Quinlan, The Royal Children’s Hospital

Kushani Jayasinghe, Monash Health

Amali Mallawaarachchi, Royal Prince Alfred Hospital

#1: POPULATION GENOMICS #2: NEXT GENERATION NEPHROLOGISTS – MAINSTREAMING CLINICAL GENOMICS #3:GENOMIC SEQUENCING IN THE RENAL CLINIC – ARE WE THERE YET #4:CLINICAL UTILITY OF WHOLE GENOME SEQUENCING IN NEPHROLOGY

Close Session Details

APSN SPEAKERS CLINICAL SCIENCE SYMPOSIUM

View Session Details

This 90 minute session will consist of 3 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Lorraine Kwan, associate consultant in the Department of Medicine, Queen Mary Hospital & Tung Wah Hospital, Hong Kong

Sunita Bavanandan, President of the Malaysian Society of Nephrology and Head of the Department of Nephrology, Hospital Kuala Lumpur, Malaysia

Yusuke Suzuki, Professor of Nephrology, Juntendo School of Medicine, Tokyo, Japan

#1: RECENT ADVANCES IN HAEMODIALYSIS #2: CLOSING THE GAPS IN PERITONEAL DIALYSIS IN THE SOUTHEAST ASIAN REGION #3: PATHOGENESIS OF IgAN AND ITS CLINICAL APPLICATION

Close Session Details

ANCA ASSOCIATED VASCULITIS – BASIC SCIENCE SYMPOSIUM

View Session Details

This 90 minute session will consist of 3 x 23-minute presentations followed by a 17-minute live Q&A where speakers will answer questions submitted by the audience.

David Jayne, Professor of Clinical Autoimmunity at the University of Cambridge, UK

Kim O’Sullivan, Monash University

Richard Kitching, Monash Univeristy

#1: COMPLEMENT IN AAV PATHOGENESIS – A NEW TARGET FOR THERAPY 2#: NEUTROPHIL ACTIVATION AND MODULATION IN ANCA VASCULITIS 3#: LOSS OF TOLERANCE AND RE-ESTABLISHING TOLERANCE TO ANCA ANTIGENS

Close Session Details

RENAL SUPPORTIVE CARE SYMPOSIUM

View Session Details

This 90 minute session will consist of 3 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Frank Brennan, Palliative Care and Renal Supportive Care Services, St George Hospital, Kogarah

Kathryn Ducharlet, Nephrology and Renal Supportive Care Services, St Vincent’s Hospital and Eastern Health

Ofra Fried, Palliative Care, Townsville University Hospital, Townsville

#1: SYMPTOM MANAGEMENT IN ADVANCED RENAL DISEASE: TASTE AND ITCH #2: COMPREHENSIVE CONSERVATIVE CARE: DEFINITIONS, EVIDENCE AND OUTCOMES #3: CROSS CULTURAL ISSUES IN END OF LIFE CARE FOR PEOPLE WITH ADVANCED RENAL DISEASE

Close Session Details

1235-1330 EXHIBITION & REFRESHMENT BREAK
Visit with our sponsors in the Exhibition Hall
CONCURRENT SESSIONS
1330-1500

The following sessions run concurrently and attendees can attend any without prior booking. Delegates may also switch between sessions after they have commenced. Unless otherwise indicated all sessions will be recorded for On-Demand viewing after the ASM.

SHAUN SUMMERS CLINICAL TRAINEE AWARD SESSION

BASIC SCIENCE AWARD SESSION

MINI ORALS #4 | GLOMERULONEPHRITIS / GENERAL NEPHROLOGY / INTERVENTIONAL NEPHROLOGY / AKI

MINI ORALS #5 | DIABETES / CARDIOVASCULAR / HYPERTENSION / HEALTH SERVICES RESEARCH

View Session Details

This 90 minute session will comprise of pre-recorded 5 minute mini oral presentations followed by a group live Q&A sessions where presenters will answer questions from the audience.

NOX5 AS A POTENTIAL BIOMARKER IN CIRCULATING PERIPHERAL BLOOD MONONUCLEAR CELLS IN CHRONIC KIDNEY DISEASE
Tomasz Block
INCIDENCE AND PREVALENCE OF MODIFIABLE CARDIOVASCULAR RISK FACTORS ACCORDING TO KIDNEY FUNCTION, GENDER AND GEOGRAPHY
Laura Cuthbertson
KIDNEY IMPLICATIONS OF THE INITIAL ESTIMATED GLOMERULAR FILTRATION RATE RESPONSE TO SODIUM GLUCOSE COTRANSPORTER-2 INHIBITION WITH EMPAGLIFLOZIN; THE ‘ESTIMATED GLOMERULAR FILTRATION RATE DIP’ IN EMPA-REG OUTCOME
Michael D’Emden
BURDEN OF CARDIOVASCULAR DISEASE AND IMPACT ON HOSPITAL ADMISSIONS, COSTS AND DEATH AMONG PRETERMINAL CHRONIC KIDNEY DISEASE PATIENTS
Vishal Diwan
EFFECT OF PHOSPHATE-LOWERING THERAPY ON CARDIAC STRUCTURE AND FUNCTION – A SUB-STUDY OF THE IMPROVE-CKD TRIAL
Nicole Lioufas
BRIEF ANGIOTENSIN CONVERTING ENZYME INHIBITION EARLY IN LIFE DELAYS THE ONSET OF ALBUMINURIA IN SHEEP BORN WITH A SOLITARY FUNCTIONING KIDNEY
Zoe McArdle
WHAT IS THE RELATIONSHIP BETWEEN CARDIOVASCULAR MORBIDITY, DEATH AND ESKF IN PATIENTS WITH DIABETES AND CKD WHO RECEIVE SPECIALIST RENAL CARE?
Ken-Soon Tan
COLLABORATIVE INDIGENOUS COMMUNITY-BASED RESEARCH: A TOOL-KIT FOR CO-CREATION AND MEANINGFUL COMMUNITY CONSULTATION
Samantha Bateman
HEALTH SERVICE COSTS FOR A PRE-DIALYSIS DIETETIC CLINIC: A RETROSPECTIVE COST ANALYSIS STUDY
Stephanie Notaras
CLINICIAN PERSPECTIVES ON DISPARITIES IN ACCESS TO KIDNEY REPLACEMENT THERAPY IN RURAL AREAS
Nicole Scholes-Robertson

Close Session Details

MINI ORALS #6 | PAEDIATRICS / GENETICS

View Session Details

This 90 minute session will comprise of pre-recorded 5 minute mini oral presentations followed by a group live Q&A sessions where presenters will answer questions from the audience.

STRATIFYING RISK OF POST TRANSPLANT RECURRENCE AND TRANSPLANT FAILURE IN CHILDREN WITH STEROID RESISTANT NEPHROTIC SYNDROME: A STUDY FROM THE AUSTRALIAN AND NEW ZEALAND PAEDIATRIC NEPHROLOGY ASSOCIATION
Anna Francis
HOMOZYGOUS VARIANTS IN NOS1AP ARE ASSOCIATED WITH STEROID RESISTANT NEPHROTIC SYNDROME IN INFANCY AND MANIFEST PODOCYTE-SPECIFIC APICOBASAL POLARITY DISTURBANCES IN IPSC DERIVED KIDNEY ORGANOIDS
Thomas Forbes
FACTORS ASSOCIATED WITH ALLOGRAFT LOSS IN AUSTRALIAN AND NEW ZEALAND PAEDIATRIC KIDNEY TRANSPLANT PATIENTS
Rowena Lalji
INCIDENCE AND PREDICTORS OF VASCULAR EVENTS FOLLOWING END STAGE KIDNEY DISEASE IN CHILDHOOD
Amelia Le Page
MULTIOMICS REVEALS EXTENSIVE MITOCHONDRIAL REMODELLING IN DIABETIC KIDNEY DISEASE
Melinda Couglan
CLINICAL IMPACT OF GENOMIC TESTING IN PATIENTS WITH SUSPECTED MONOGENIC KIDNEY DISEASE
Kushani Jayasinghe
ATTITUDES AND PRACTICES OF AUSTRALIAN NEPHROLOGISTS TOWARDS IMPLEMENTATION OF CLINICAL GENOMICS
Kushani Jayasinghe
EARLY GENOMIC SEQUENCING INCREASES DIAGNOSTIC YIELD AND IS COST EFFECTIVE IN CHILDREN
Kushani Jayasinghe
NATIONWIDE DIAGNOSTIC UTILITY OF CLINICAL GENOMICS IN PATIENTS WITH SUSPECTED GENETIC KIDNEY DISEASE
Kushani Jayasinghe
THE HERITABILITY OF KIDNEY FUNCTION USING AN OLDER AUSTRALIAN TWIN POPULATION
Julia Jefferis
PHARMACOGENOMICS FOR CHRONIC DISEASE MEDICINES IN AN AUSTRALIAN INDIGENOUS POPULATION
Wendy Hoy

Close Session Details

1500-1505
5 min changeover break
PLENARY #4
HD VASCULAR ACCESS MONITORING/SURVEILLANCE: SINE QUA NON?
1505-1610
Professor Yong-Soo Kim
Professor of Medicine in the Catholic University of Korea College of Medicine in Seoul, Korea
SPEED NETWORKING SOCIAL
1610-1630

DAY TWO CONCLUDES
The Networking Hub remains open for scheduled meetings with sponsors and other attendees.  Schedule a meeting through the Networking Hub.
Wednesday, 2nd December 2020
CONCURRENT SESSIONS
0930-1100

The following sessions run concurrently and attendees can attend any without prior booking. Delegates may also switch between sessions after they have commenced. Unless otherwise indicated all sessions will be recorded for On-Demand viewing after the ASM.

GLOMERULAR BASEMENT MEMBRANE & KIDNEY DISEASE – BASIC SCIENCE SYMPOSIUM

View Session Details

This 90 minute session will consist of 4 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Rachel Lennon, The University of Manchester, UK

Andrew Mallett, Townsville University Hospital

Ella Wilkins, The Royal Children’s Hospital Renal Genetics Clinic

Judy Savige, Melbourne Health

#1:THE GLOMERULAR MATRISOME IN HEALTH AND DISEASE #2:GENE AND VARIANT CURATION IN GENETIC KIDNEY DISEASE – PATHWAYS FOR SUCCESS #3: FAMILY MATTERS: GENETIC COUNSELLING AND TESTING FOR ALPORT SYNDROME #4: WHAT YOU NEED TO KNOW ABOUT ALPORT SYNDROME

Close Session Details

PCKD SYMPOSIUM

View Session Details

This 90 minute session will consist of 3 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Session Moderators: Natasha Rogers, Greg Tesch 

Yeoungjee Cho, Centre for Health Services Research The University of Queensland

Ian Smyth, Monash Biomedicine Discovery Institute, Monash University

Gopi Rangan, Westmead Institute for Medical Research, University of Sydney

#1: CORE OUTCOMES FOR TRIALS IN ADPKD: THE SONG_PKD INITIATIVE #2: IDENTIFICATION OF A NEW REGULATOR OF CYST DEVELOPMENT IN DIFFERENT TYPES OF PKD #3: DNA DAMAGE RESPONSE PATHWAYS IN POLYSYSTIC KIDNEY DISEASE

Close Session Details

ANZDATA SYMPOSIUM

View Session Details

Session details and presenters to be advised.

Close Session Details

GREEN NEPHROLOGY SYMPOSIUM

View Session Details

This 90 minute session will consist of 4 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Sarah Brown, Purple House

John Knight, The George Institute for Global Health and University of New South Wales

Katherine Barraclough, Royal Melbourne Hospital and University of Melbourne

David Johnson, Princess Alexandra Hospital and University of Queensland

#1: HAEMODIALYSIS PROVISION IN THE CONTEXT OF CLIMATE CHANGE #2: THE CARBON FOOTPRINT OF PD AND ENVIRONMENTAL WINS FROM THE ELLEN MEDICAL PD SYSTEM #3: KIDNEY PATIENT CARE IN NATURAL DISASTERS: EMERGENCY PLANNING FOR PATIENTS AND DIALYSIS UNITS #4: KIDNEY PATIENT CARE IN NATURAL DISASTERS: EMERGENCY PLANNING FOR PATIENTS AND DIALYSIS UNITS

Close Session Details

1100-1200 EXHIBITION & REFRESHMENT BREAK
Visit with our sponsors in the Exhibition Hall
PLENARY #5 – AWARD PRESENTATIONS
1200-1330

TJ Neale – 2020 Award Presentation
Professor Angela Webster
Clinical Epidemiologist, Nephrologist and Transplant Physician, Westmead Hospital
Jacquot Awardee Presentations
Dr Anna Francis
Paediatric nephrologist and clinician researcher with the Queensland Children’s Hospital, and a Jacquot Research Entry Award Entry winner 2017 and 2018, who will speak on the topic of Improving the long-term outcomes for children with CKD
Associate Professor Natasha Rogers
Westmead Hospital, and a Jacquot Research Establishment Award winner in 2016 and 2018
PLENARY #6 – COVID SYMPOSIUM
1330-1500

COVID-19 – AN INSIGHT INTO EXTREME PANDEMIC CONDITIONS
Dr Philip Masson
Consultant Nephrologist, Royal Free Hospital, UK
COVID-19 PANDEMIC AND THE AUSTRALIAN HEALTH PERSPECTIVE
Professor Brendan Murphy
Commonwealth Secretary of Health
Panel Discussion
1500-1530 EXHIBITION & REFRESHMENT BREAK
Visit with our sponsors in the Exhibition Hall
CONCURRENT SESSIONS
1530-1700

The following sessions run concurrently and attendees can attend any without prior booking. Delegates may also switch between sessions after they have commenced. Unless otherwise indicated all sessions will be recorded for On-Demand viewing after the ASM.

AUSTRALIAN KIDNEY TRIALS NETWORK (AKTN) SYMPOSIUM

View Session Details

Chaired by Matthew Roberts and Carmel Hawley, this 90 minute session will be broken into three sections:

#1: Clinical Trials: From inception to publication and beyond

#2: Adapting to a changing clinical trials landscape

#3: Engaging with the AKTN

Nigel Toussaint, Interim Director of Nephrology, The Royal Melbourne Hospital; Clinical Associate Professor, University of Melbourne

 

David Johnson, Princess Alexandra Hospital and University of Queensland

Andrea Viecelli, Nephrologist, Princess Alexandra Hospital and University of Queensland

Yeoungjee Cho, Centre for Health Services Research The University of Queensland

#1: IMPROVE-CKD #2: CKD-FIX #3: WHATS NEW FOR AKTN TRIALS #4: OPPORTUNITIES AND PATHWAYS FOR ENGAGEMENT

Close Session Details

GENDER EQUALITY IN MEDICINE, NEPHROLOGY & OUR SOCIETY SYMPOSIUM

View Session Details

This 60 minute session will consist of an introduction from the chair, Kate Wyburn followed by 2 presentations.

Patrick (Paddy) Mark, Professory of Nephrology and Honorary Consultant Nephrologist at the Glasgow Renal and Transplant Unit based at the Queen Elizabeth University Hospital Glasgow

Lisa Guay-Woodford, McGehee Joyce Professor of Pediatrics at the Children’s National Medical Center (CNMC), Washington

#1: GENDER EQUITY IN NEPHROLOGY – INSIGHTS FROM SCOTLAND! #2: To be advised

Close Session Details

SELECTED NEPHROLOGY UPDATES

View Session Details

This 90 minute session will consist of 3 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Simon Jiang, John Curtin School of Medical Research and Centre for Personalised Immunology

Peter Hughes

Jeremy Chapman, Westmead Hospital, Sydney 

#1: PERSONALISED MOLECULAR GENETICS IN LUPUS #2: ANZKX #3To be advised

Close Session Details

MINI ORALS #7 | TRANSPLANTATION / EXPERIMENTAL IMMUNOLOGY

MINI ORALS #8 | HAEMODIALYSIS

View Session Details

This 90 minute session will comprise of pre-recorded 5 minute mini oral presentations followed by a group live Q&A sessions where presenters will answer questions from the audience.

EXERCISE TRAINING TO IMPROVE PATIENT-IMPORTANT OUTCOMES IN ADULTS UNDERGOING MAINTENANCE DIALYSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
Amélie Bernier-Jean
PHYSICAL ACTIVITY AND MORTALITY IN ADULTS UNDERGOING HAEMODIALYSIS: A DIET-HD COHORT STUDY
Amélie Bernier-Jean
DIETARY HABITS IN AUSTRALIAN, NEW ZEALAND AND MALAYSIAN PATIENTS WITH END STAGE KIDNEY DISEASE; A PRE-SPECIFIED ANALYSIS OF THE FAVOURED TRIAL PARTICIPANTS
Marguerite Conley
PATIENTS’ EXPERIENCES OF A MOBILE PHONE TEXT MESSAGE INTERVENTION TO IMPROVE DIETARY BEHAVIOURS IN HAEMODIALYSIS (KIDNEYTEXT)
Jessica Dawson
COST-EFFECTIVENESS OF A MOBILE PHONE TEXT MESSAGING INTERVENTION (KIDNEYTEXT) TO IMPROVE DIETARY BEHAVIOURS IN PEOPLE RECEIVING HAEMODIALYSIS
Jessica Dawson
WELLBEING INTERVENTION FOR CHRONIC KIDNEY DISEASE: THE WICKD TRIAL
Jaquelyne Hughes
THE EFFICIENCY OF A NOVEL ASYMMETRICAL CELLULOSE TRIACETATE DIALYSIS MEMBRANE COMPARED TO A STANDARD HIGH-FLUX DIALYSIS MEMBRANE; A PILOT STUDY
Kamya Kameshwar
SEX DISPARITY IN CAUSE-SPECIFIC MORTALITY IN PATIENTS WITH KIDNEY FAILURE
Kimberley Sonya Minas
FEASIBILITY AND ACCEPTABILITY OF ELECTRONIC PATIENT REPORTED OUTCOME MEASURES (E-PROMS) DATA CAPTURE IN THE SYMPTOM MONITORING WITH FEEDBACK TRIAL (SWIFT) PILOT: PERSPECTIVES OF NEPHROLOGISTS, NURSES AND PATIENTS
Rachael Morton
FEASIBILITY AND ACCEPTABILITY OF SYMPTOM MONITORING WITH FEEDBACK TRIAL (SWIFT) FOR ADULTS ON HAEMODIALYSIS: A PILOT ANZDATA REGISTRY-BASED CLUSTER RANDOMISED TRIAL
Rachael Morton
ASSOCIATIONS BETWEEN PLANT-BASED DIET QUALITY, UREMIC TOXINS, AND GUT MICROBIOTA PROFILE IN ADULTS UNDERGOING HEMODIALYSIS THERAPY
Jordan Stanford

Close Session Details

1700-1705
5 minute changeover
PLENARY #6
1705-1735
MEETING OVERVIEW: HIGHLIGHTS, HOT TOPICS & FUTURE DIRECTIONS

Neil Boudville, ANZSN President
DAY THREE CONCLUDES
Thank you for attending the 2020 Virtual ASM.  Recordings of sessions will be available on the platform for one month proceeding the ASM dates.  Exact dates to be advised.
Recent Comments
    Categories